NCT07645352
Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 Zimbabwe
StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
At risk: Primary completion moved 7 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Study completion pushed from Dec 31, 2027 to May 31, 2028
- Notable Recruitment opened
- Site details revised
- Notable Primary and study completion pushed from May 31, 2027 to Dec 31, 2027
- Notable Eligibility criteria expanded, about 16 words
- Start date: Oct 2026 to Oct 15, 2026
- Collaborators: details revised at 1 of 6 entries
- Notable Start date: Jun 2026 to Oct 2026v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Proportion of participants with persistent HPV at 6 months
Timeframe: From enrollment to follow up at 6 months
Arms and interventions
Group 1 (TA with 1 probe)Experimental
Participants undergo a clinical exam, soft-brush endocervical and ectocervical biopsies, digital imaging, and visual assessment for TA, and if eligible undergo TA with 1 probe at month 0.
Group 2 (TA with 2 probes)Experimental
Participants undergo a clinical exam, soft-brush endocervical and ectocervical biopsies, digital imaging, and visual assessment for TA, and if eligible undergo TA with 2 probes at month 0.
Procedures: Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes
Sites
1 site in 1 country
- University of Zimbabwe, Centre for ResearchHarare, Zimbabwe